153 related articles for article (PubMed ID: 34641931)
1. Clinical and ultrasound characteristics of virilizing ovarian tumors in pre- and postmenopausal patients: a single tertiary center experience.
Zou M; Chen R; Wang Y; He Y; Wang Y; Dong Y; Li J
Orphanet J Rare Dis; 2021 Oct; 16(1):426. PubMed ID: 34641931
[TBL] [Abstract][Full Text] [Related]
2. Discriminating between virilizing ovary tumors and ovary hyperthecosis in postmenopausal women: clinical data, hormonal profiles and image studies.
Yance VRV; Marcondes JAM; Rocha MP; Barcellos CRG; Dantas WS; Avila AFA; Baroni RH; Carvalho FM; Hayashida SAY; Mendonca BB; Domenice S
Eur J Endocrinol; 2017 Jul; 177(1):93-102. PubMed ID: 28432270
[TBL] [Abstract][Full Text] [Related]
3. Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis.
Mamoojee Y; Ganguri M; Taylor N; Quinton R
Clin Endocrinol (Oxf); 2018 Jan; 88(1):13-20. PubMed ID: 28980338
[TBL] [Abstract][Full Text] [Related]
4. Dexamethasone suppression test versus selective ovarian and adrenal vein catheterization in identifying virilizing tumors in postmenopausal hyperandrogenism - a systematic review and meta-analysis.
Tng EL; Tan JM
Gynecol Endocrinol; 2021 Jul; 37(7):600-608. PubMed ID: 33660585
[TBL] [Abstract][Full Text] [Related]
5. An ovarian Leydig cell tumor of ultrasound negative in a postmenopausal woman with hirsutism and hyperandrogenism: A case report.
Chen M; Zhou W; Zhang Z; Zou Y; Li C
Medicine (Baltimore); 2018 Mar; 97(10):e0093. PubMed ID: 29517680
[TBL] [Abstract][Full Text] [Related]
6. Persistent Poor Metabolic Profile in Postmenopausal Women With Ovarian Hyperandrogenism After Testosterone Level Normalization.
Rocha T; Crespo RP; Yance VVR; Hayashida SA; Baracat EC; Carvalho F; Domenice S; Mendonca BB; Gomes LG
J Endocr Soc; 2019 May; 3(5):1087-1096. PubMed ID: 31073547
[TBL] [Abstract][Full Text] [Related]
7. Approach to Investigation of Hyperandrogenism in a Postmenopausal Woman.
Hirschberg AL
J Clin Endocrinol Metab; 2023 Apr; 108(5):1243-1253. PubMed ID: 36409990
[TBL] [Abstract][Full Text] [Related]
8. Impact of clinical, hormonal, radiological, and immunohistochemical studies on the diagnosis of postmenopausal hyperandrogenism.
Sarfati J; Bachelot A; Coussieu C; Meduri G; Touraine P;
Eur J Endocrinol; 2011 Nov; 165(5):779-88. PubMed ID: 21896622
[TBL] [Abstract][Full Text] [Related]
9. Virilising ovarian tumors: a single-center experience.
Sehemby M; Bansal P; Sarathi V; Kolhe A; Kothari K; Jadhav-Ramteke S; Lila AR; Bandgar T; Shah NS
Endocr Connect; 2018 Dec; 7(12):1362-1369. PubMed ID: 30400027
[TBL] [Abstract][Full Text] [Related]
10. Postmenopausal hyperandrogenism.
Yoldemir T
Climacteric; 2022 Apr; 25(2):109-117. PubMed ID: 33988479
[TBL] [Abstract][Full Text] [Related]
11. Virilizing ovarian tumor of cell tumor type not otherwise specified: a case report.
Faraj G; Di Gregorio S; Misiunas A; Faure EN; Villabrile P; Stringa I; Petroff N; Bur G
Gynecol Endocrinol; 1998 Oct; 12(5):347-52. PubMed ID: 9859028
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Thresholds for Androgen-Producing Tumors or Pathologic Hyperandrogenism in Women by Use of Total Testosterone Concentrations Measured by Liquid Chromatography-Tandem Mass Spectrometry.
Sharma A; Kapoor E; Singh RJ; Chang AY; Erickson D
Clin Chem; 2018 Nov; 64(11):1636-1645. PubMed ID: 30068692
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic pitfalls in ovarian androgen-secreting (Leydig cell) tumours: case series.
Fanta M; Fischerová D; Indrielle-Kelly T; Koliba P; Zdeňková A; Burgetová A; Vrbíková J
J Obstet Gynaecol; 2019 Apr; 39(3):359-364. PubMed ID: 30428740
[TBL] [Abstract][Full Text] [Related]
14. Is ovarian and adrenal venous catheterization and sampling helpful in the investigation of hyperandrogenic women?
Kaltsas GA; Mukherjee JJ; Kola B; Isidori AM; Hanson JA; Dacie JE; Reznek R; Monson JP; Grossman AB
Clin Endocrinol (Oxf); 2003 Jul; 59(1):34-43. PubMed ID: 12807501
[TBL] [Abstract][Full Text] [Related]
15. Ovarian Leydig Cell Tumor and Ovarian Hyperthecosis in a Postmenopausal Woman: A Case Report and Literature Review.
Bužinskienė D; Marčiukaitytė R; Šidlovska E; Rudaitis V
Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374301
[TBL] [Abstract][Full Text] [Related]
16. Serum HE4 and diagnosis of ovarian cancer in postmenopausal women with adnexal masses.
Gentry-Maharaj A; Burnell M; Dilley J; Ryan A; Karpinskyj C; Gunu R; Mallett S; Deeks J; Campbell S; Jacobs I; Sundar S; Menon U
Am J Obstet Gynecol; 2020 Jan; 222(1):56.e1-56.e17. PubMed ID: 31351062
[TBL] [Abstract][Full Text] [Related]
17. Hyperandrogenism in a postmenopausal woman: diagnostic and therapeutic challenges.
Cheng V; Doshi KB; Falcone T; Faiman C
Endocr Pract; 2011; 17(2):e21-5. PubMed ID: 21247854
[TBL] [Abstract][Full Text] [Related]
18. Retrospective analysis of transvaginal ultrasound-guided aspiration of simple ovarian cysts.
Kostrzewa M; Zając A; Wilczyński JR; Stachowiak G
Adv Clin Exp Med; 2019 Nov; 28(11):1531-1535. PubMed ID: 31660708
[TBL] [Abstract][Full Text] [Related]
19. Analysis of false negative results of subjective ultrasonography assessment of adnexal masses.
Moszynski R; Szpurek D; Szubert S; Sajdak S
Ginekol Pol; 2013 Feb; 84(2):102-7. PubMed ID: 23668055
[TBL] [Abstract][Full Text] [Related]
20. Ultrasound characteristics of early-stage high-grade serous ovarian cancer.
Suh-Burgmann E; Brasic N; Jha P; Hung YY; Goldstein RB
Am J Obstet Gynecol; 2021 Oct; 225(4):409.e1-409.e8. PubMed ID: 33992598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
